期刊文献+

人用疫苗佐剂的研究现状 被引量:4

Development of Human Vaccine Adjuvants
下载PDF
导出
摘要 概述人用疫苗佐剂近年来的研究进展 ,主要涉及微生物来源佐剂、乳剂型佐剂、微粒型佐剂及合成佐剂等 ,介绍若干进入临床前和临床评价的新型佐剂产品 ,其中 QS2 1、ISCOMs、生物可降解聚合微球、Cp G ODN及 MF5 Development of human vaccine adjuvant s including microgram derived adjuvants, emulsions, particulate adjuvants and sy nthetic adjuvants were reviewed and several novel adjuvant candidates in pro-cl inical and clinical trials were introduced. QS21, ISCOMs, biodegradable polymer microspheres, CpG ODN and MF59 have broad prospects for clinical application as novel human vaccine adjuvants.
出处 《药学进展》 CAS 2001年第4期207-210,共4页 Progress in Pharmaceutical Sciences
关键词 人用疫苗佐剂 微生物来源佐剂 生物可降解聚合微球 非离子阻断聚合物 合成佐剂 Human vaccine adjuvant Microgram derived adjuva nt Biodegradable polymer microsphere Nonionic block copolymer Synthetic adjuvan t
  • 相关文献

参考文献15

  • 1[1]Chiaramonte MG, Hesse M, Cheever AW, et al. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism[J]. J Immuunol, 2000,164(2): 973-985.
  • 2[2]Brandt L, Elhay M, Rosenkrands I, et al. ESAT-6 subunit vaccination against mycobacterium tuberculosis[J]. Infect Immun, 2000,68(2) :791-795.
  • 3[3]Hansen G, Yeung VP, Berry G, et al. Vaccination with heat-killed Listeria as adjuvant reverses established allergeninduced airway hyperreactivity and inflammation: role of CD8-+- T cells and IL-18[J]. J Immunol, 2000, 164(1):223-230.
  • 4[4]Simmons CP, Mastroeni P, Fowler R, et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants[J]. J Immunol, 1999,163(12):6502-6510.
  • 5[5]Ennis FA, Cruz J, Jameson J, et al. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS) [J].Virology, 1999, 259(2): 256-261.
  • 6[6]Mowat AM, Smith RE, Donachie AM, et al. Oral vaccination with immune stimulating complexes[J]. Immunol Lett,1999, 65(1-2): 133-140.
  • 7[7]Nakanishi T, Kunisawa J, Hayashi A, et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins [J].J Controlled Release, 1999,61(1-2):233-240.
  • 8[8]Krishnan L, Dicaire CJ, Patel GB, et al. Archaeosome vaccine adjuvants induce strong humoral, cell- mediated, and memory responses: comparison to conventional llposomes and alum[J]. Infect Immun,2000,68(1):54-63.
  • 9[9]Whitmore M, Li S, Huang L. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth[J]. Gene Ther, 1999,6 (11 ): 1867-1875.
  • 10[10]Tuo W, Palmer GH, McGuire TC, et al. Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen anaplasma marginale[J]. Infect Immun,2000,68(1): 270-280.

同被引文献85

  • 1靳玄烨,谢吉科,杨艳.脂质体制剂稳定性研究进展[J].河北医科大学学报,2004,25(6):374-376. 被引量:8
  • 2周红蕾,李春玲,王贵平,侯加法.脂质体作为疫苗免疫佐剂的应用研究进展[J].动物医学进展,2006,27(2):34-38. 被引量:7
  • 3陈庆华,瞿文.多肽、蛋白质药物的微球给药系统研究进展[J].国外医学(药学分册),1997,24(3):129-133. 被引量:20
  • 4Ninomiya A, Riddell M A, Gidding H F. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in miee[J]. Vaccine, 2002, 20(25 - 26) :3123.
  • 5Babai I, Barenholz Y, Zakay R Z. A novel liposomal influenza vaccine (INFLUSOME- VAC) containing hemagglutininneuraminidase and IL-2 or GM - CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains [J]. Vaccine, 2001, 20 ( 3 - 4) :505.
  • 6Ernst W A, Kim H J, Tumpey T M. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitop vaccines[J]. Vaccine ,2006,24(24) ..5 158.
  • 7Wang C Y, Yughes K W, Huang L. Improved cytoplasmic delivery to plant protoplasts via PH2sensitive liposome[J]. Plant Physiol, 1986,8(2) : 179.
  • 8曾昭钧.均匀设计及其应用[M].沈阳:辽宁人民卫生出版社,1994..
  • 9Marciani DJ. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity[J]. Drug Discov Today, 2003, 8(20):934-943.
  • 10Corsi K, Chellat F, Yahia L, et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J]. Biomaterials, 2003, 24(7): 1255-1264.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部